Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPD602 vs Deferasirox for Iron Overload in Beta-thalassemia
NCT01927913Phase 2Withdrawn
- Sponsor
- Takeda
- Start
- Nov 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of deferitazole in iron overload, sponsored by Takeda. Planned start Nov 2014; status: withdrawn.
02
Drugs
deferitazole
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT01927913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01927913.